Want to see TSE:BUX full AI Analyst Report?
BioMark Diagnostics (BUX) Income Statement
BioMark Diagnostics Income Statement
Last quarter (Q4 2026), BioMark Diagnostics's total revenue was $7.01K, a decrease of 82.03% from the same quarter last year. In Q4, BioMark Diagnostics's net income was $-199.47K. See BioMark Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| $ 59.79K | $ 154.22K | $ 163.22K | $ 43.93K | $ 0.00 | |
| $ -322.49K | $ 154.22K | $ 163.22K | $ 43.93K | $ -13.69K | |
| $ 1.55M | $ 2.06M | $ 1.48M | $ 1.45M | $ 1.08M | |
| Depreciation and Amortization | $ 382.28K | $ 401.27K | $ 393.17K | $ 179.62K | $ 13.69K |
| $ -1.49M | $ -1.46M | $ -919.05K | $ -1.22M | $ -1.08M | |
| $ -1.87M | $ -1.91M | $ -1.32M | $ -1.28M | $ -1.09M | |
| $ 268.36K | $ -19.14K | $ -110.67K | $ -50.80K | $ -596.00 | |
| $ -1.60M | $ -1.93M | $ -1.43M | $ -1.45M | $ -1.09M | |
| $ -1.48M | $ -1.93M | $ -1.43M | $ -1.45M | $ -1.09M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.01 |
| Diluted EPS | $ -0.01 | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.01 |
| Weighted Average Shares Outstanding | 105.09M | 85.24M | 85.24M | 72.31M | 73.30M |
| Weighted Average Shares Outstanding (Diluted) | 105.09M | 85.24M | 85.24M | 72.31M | 73.30M |
Currency in CAD
